Recruiting

EveryDose©

Sponsor:

University of Miami

Code:

NCT06952790

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EveryDose Mobile Application

Study Details

Brief summary:

The purpose of this study is to learn about the experiences of cancer patients during treatment utilizing a mobile app called EveryDose© to track prescribed oral treatment for cancer. Based on these experiences, the study team will decide on expanding this pilot study to evaluate other methods that may prove to be beneficial in supporting cancer patient's ability to take cancer medications as prescribed (another common phrase used for this is adherence to treatment).

Conditions

Cancer

Study ID

NCT06952790

Start date

Oct 2, 2025

Status verified date

Aug, 2026

Completion date

Jan 1, 2027

Anticipated

Primary completion date

Jan 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Any sex/gender Able to provide written informed consent
  • Able to read/understand English or Spanish
  • Diagnosis of hematologic or solid tumor cancer diagnosis
  • Prescribed an oral anti-cancer drug as monotherapy treatment for the first time by their treating oncologist.
  • Internet access on a smartphone, tablet, or computer

Exclusion Criteria:

  • Less than 18 years of age
  • Unable to provide written informed consent
  • Unable to read/understand English or Spanish
  • History of dementia or major psychiatric disease that would interfere with study participation
  • Prior treatment with an oral anti-cancer treatment
  • Participating in another clinical trial during the time of screening.

Study Design

Enrollment

25 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: EveryDose Mobile Application Group

Participants in this group will use the EveryDose mobile application for up to 12 weeks.

Interventions

EveryDose Mobile Application

Participants will use this application every day for up to 10 minutes, for up to 12 weeks. The purpose of the application is to improve medication adherence. Participants will receive an alert to the mobile device while at home to ensure medication was taken, and to serve as a medication log.

Primary outcome measure

  • Percentage of patients who agree to use the EveryDose application [ Time Frame: up to 12 weeks ]
  • EveryDose application adherence measured by percentage [ Time Frame: up to 12 weeks ]
  • Medication Adherence measured by dose ratio [ Time Frame: up to 12 weeks ]

Central Contacts and Locations

Central contacts

Jessica MacIntyre, DNP

305-243-4570jmacintyre@med.miami.edu

Locations

University of Miami

Recruiting

Miami, Florida, United States, 33136

Contacts

Aaron Riffa, BSN

305-243-5716aaronriffa@med.miami.edu

Principal Investigator:

Frank Penedo, PhD

More Information

Sponsor

University of Miami

Last update posted

Aug 28, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Miami on 2026-08-28.